Patents by Inventor Susan Boyles

Susan Boyles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11357758
    Abstract: Provided are epithelial cell spheroids including spheroids that have apical membranes and cilia that face towards the interior core of the spheroid and spheroids that have apical membranes and cilia that face away from the interior core of the spheroid. Also provided methods of making and using such spheroids.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: June 14, 2022
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Martina Gentzsch, Scott Randell, Nancy L. Quinney, Susan Boyles, Jennifer Guimbellot
  • Patent number: 9861619
    Abstract: Compositions and methods are provided for treating or inhibiting a bacterial infection involving at least one antibiotic and a compound that potentiates the antibiotic activity of the antibiotic. In certain embodiments the antibiotic is a beta lactam. In further embodiments, the antibiotic is oxacillin. In additional embodiments, the potentiating compound is an inhibitor of vraSR operon expression. In specific embodiments, the bacterial infection involves an antibiotic-resistant bacteria.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: January 9, 2018
    Assignee: The University of Chicago
    Inventors: Robert S. Daum, Susan Boyle-Vavra
  • Publication number: 20170273954
    Abstract: Compositions and methods are provided for treating or inhibiting a bacterial infection involving at least one antibiotic and a compound that potentiates the antibiotic activity of the antibiotic. In certain embodiments the antibiotic is a beta lactam. In further embodiments, the antibiotic is oxacillin. In additional embodiments, the potentiating compound is an inhibitor of vraSR operon expression. In specific embodiments, the bacterial infection involves an antibiotic-resistant bacteria.
    Type: Application
    Filed: June 9, 2017
    Publication date: September 28, 2017
    Applicants: THE UNIVERSITY OF CHICAGO, THE BOARD OF REGENTS OF THE UNIVERSITY OF ILLINOIS
    Inventors: Robert S. Daum, Susan Boyle-Vavra, Michael E. Johnson
  • Publication number: 20170242033
    Abstract: Provided are epithelial cell spheroids including spheroids that have apical membranes and cilia that face towards the interior core of the spheroid and spheroids that have apical membranes and cilia that face away from the interior core of the spheroid. Also provided methods of making and using such spheroids.
    Type: Application
    Filed: February 23, 2017
    Publication date: August 24, 2017
    Inventors: Martina Gentzsch, Scott Randell, Nancy L. Quinney, Susan Boyles, Jennifer Guimbellot
  • Patent number: 9675592
    Abstract: Compositions and methods are provided for treating or inhibiting a bacterial infection involving at least one antibiotic and a compound that potentiates the antibiotic activity of the antibiotic. In certain embodiments the antibiotic is a beta lactam. In further embodiments, the antibiotic is oxacillin. In additional embodiments, the potentiating compound is an inhibitor of vraSR operon expression. In specific embodiments, the bacterial infection involves an antibiotic-resistant bacteria.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: June 13, 2017
    Assignees: The University of Chicago, The Board of Regents of the University of Illinois
    Inventors: Robert S. Daum, Susan Boyle-Vavra, Michael E. Johnson
  • Publication number: 20160120852
    Abstract: Compositions and methods are provided for treating or inhibiting a bacterial infection involving at least one antibiotic and a compound that potentiates the antibiotic activity of the antibiotic. In certain embodiments the antibiotic is a beta lactam. In further embodiments, the antibiotic is oxacillin. In additional embodiments, the potentiating compound is an inhibitor of vraSR operon expression. In specific embodiments, the bacterial infection involves an antibiotic-resistant bacteria.
    Type: Application
    Filed: March 14, 2014
    Publication date: May 5, 2016
    Applicants: THE BOARD OF REGENTS OF THE UNIVERSITY OF ILLINOIS, THE UNIVERSITY OF CHICAGO
    Inventors: Robert S. DAUM, Susan BOYLE-VAVRA, Michael E. JOHNSON
  • Publication number: 20150283120
    Abstract: Compositions and methods are provided for treating or inhibiting a bacterial infection involving at least one antibiotic and a compound that potentiates the antibiotic activity of the antibiotic. In certain embodiments the antibiotic is a beta lactam. In further embodiments, the antibiotic is oxacillin. In additional embodiments, the potentiating compound is an inhibitor of vraSR operon expression. In specific embodiments, the bacterial infection involves an antibiotic-resistant bacteria.
    Type: Application
    Filed: November 1, 2013
    Publication date: October 8, 2015
    Applicant: The University of Chicago
    Inventors: Robert S. Daum, Susan Boyle-Vavra